Teva Recalls One Lot Of IDArubicin Hydrochloride Injection

PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals has initiated a recall of lot 31329657B of IDArubicin Hydrochloride Injection USP 5 mg/5 mL vial in the United States due to the possible presence of

Related Keywords

United States , ,Drug Administration ,Teva Pharmaceuticals United States Inc ,Teva Pharmaceuticals ,Hydrochloride Injection ,Teva Pharmaceuticals United States ,Fresenius Kabi United States ,Sodium Acetate Injection ,Teva ,Recalls ,Darubicin ,Hydrochloride ,Injection ,